27 results
COVID-19 Diagnosis and Management Summary

 • Clinical Presentation
 • Testing
 • Imaging
 • Laboratory Findings
 •
COVID-19 Diagnosis ... and Management ... #COVID19 #diagnosis ... #management #treatment ... #summary #sarscov2
Hypereosinophilia (HE) Summary

 • Definition
 • When to Suspect?
 • A Partial Classification of Hypereosinophilia
 •
Hypereosinophilia (HE) Summary ... Hypereosinophilia • Diagnostic ... Presentations • Treatment ... Hypereosinophilia #HE #hematology ... #diagnosis #management
Non-HCV infectious mixed cryoglobulinemia vasculitis - Diagnosis, causes and management - French Vasculitis Study Group

< 5%
- Diagnosis, causes ... and management ... neuropathy Treatment ... #Rheumatology # ... #Management
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
and Management ... Summary myelo ( ... only curative treatment ... #Management #treatment ... #hematology #oncology
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
emergency 2020-3-12 Diagnosis ... illness) • 20-40% dyspnea ... #Cheatsheet #Diagnosis ... #Management #Summary ... #SARSCoV2 #Coronavirus
Kawasaki Disease (KD) - Diagnosis and Management Summary

Kawasaki Disease (KD) is the most common vasculitis of
Summary Kawasaki ... the most common vasculitis ... #Disease #KD #vasculitis ... #rheumatology # ... #management #treatment
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Erythematosus (SLE) - Diagnosis ... Summary • Epidemiology ... life-threatening • Treatment ... #Management #Summary ... #rheumatology
Polycythemia Vera (PV) - Diagnosis and Management Summary
Diagnostic Criteria:
 • Elevated hemoglobin and/or hematocrit AND
 •
Polycythemia Vera (PV) - Diagnosis ... and Management ... Summary Diagnostic ... #Management #Summary ... #treatment #hematology
Systemic Lupus Erythematosus - Summary
Antinuclear (ANA) - 95% - Initial screening test
Anti-dsDNA - 50%
 • Associated
Erythematosus - Summary ... severe disease Treatment ... Erythematosus #SLE #Summary ... #diagnosis #rheumatology ... #management
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
with response to treatment ... No necrosis, No vasculitis ... #management #phenotypes ... #workup #treatment ... #rheumatology